Photosensitivity Proof of Concept Trial
NCT00894010
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
6
Enrollment
OTHER
Sponsor class
Conditions
Photosensitive Epilepsy
Interventions
DRUG:
carbamazepine 400mg
DRUG:
levetiracetam 1000mg
Sponsor
The Epilepsy Study Consortium
Collaborators
[object Object]
[object Object]